Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations - 2FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 3Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims
- 4Clocks to go forward one hour in Europe as summer time starts
- 5Attorney-General to High Court: Gov’t violating draft ruling, risking rule of law
- Finding the Universe of Workmanship: Individual Encounters in Imagination
- Factbox-Artemis II crew includes first woman, Black astronaut and Canadian ever flown to moon
- Ancient meditation practices find new life in modern religious communities across America
- Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title
- Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- Manual for Tracking down One of a kind Store Inns
- Best Wellness Tracker Keep You On target
- 25 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
- Dancing through the crackdown: The satirical song soundtracking post-Khamenei Iran
